Table 2 Performance of diagnostic and therapeutic procedures
With mediastinoscopy (n=) | Without mediastinoscopy (n=) | |
|---|---|---|
EBUS, No. (%) | ||
Additional EUS | ||
EUS, No. (%) | ||
EUS-B, No. (%) | ||
Rapid on-site evaluation, No. (%) | ||
Mediastinal lymph node stations | ||
Visualised, mean (SD)/median (IQR) | ||
Sampled, mean (SD)/median (IQR) | ||
Samples per station, mean (SD)/median (IQR) | ||
Cytologically proven N1 disease, No. (%) | ||
Confirmatory mediastinoscopy, No. (%) | 0 | |
Mediastinal lymph node stations | – | |
Sampled, mean (SD)/median (IQR) | ||
Adequate samplinga, % | – | |
Proven mediastinal lymph node metastases | – | |
N2, No (%) | ||
N3, No. (%) | – | |
Complete mediastinoscopyb, No. (%) | ||
Anatomical lung resection, No. (%) | ||
Thoracoscopic surgery, No. (%) | ||
Conversion to thoracotomy, No. (%) | ||
Duration of surgery, mean (SD)/median (IQR) minutes | ||
Resection type | ||
Segmentectomy, No. (%) | ||
Lobectomy, No. (%) | ||
Bilobectomy, No. (%) | ||
Pneumonectomy, No. (%) | ||
Mediastinal lymph node stations dissected, mean (SD)/median (IQR) | ||
Complete lobe-specific lymph node dissectionb, No. (%) | ||
Unforeseen N2, No. (%) | ||
Foreseen N2 (station 5–6), No. (%) | ||